Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography

被引:44
作者
Li, CH [1 ]
Sutherland, CA [1 ]
Nightingale, CH [1 ]
Nicolau, DP [1 ]
机构
[1] Hartford Hosp, Ctr Anti Infect Res & Dev, Hartford, CT 06102 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 811卷 / 02期
关键词
tigecycline; HPLC;
D O I
10.1016/j.jchromb.2004.09.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An ion-paired HPLC assay was developed to determine tigecycline (GAR-936) concentrations in Hank's balanced salts solution, tigecycline intra-cellular concentrations in human polymorphonuclear neutrophils (PMNs) and tigecycline concentrations in human serum. Minocycline was used as internal standard, 5% trichloroacetic acid was added to lyse PMNs and also precipitate proteins in PMNs and serum. The top aqueous layer was aspirated for HPLC assay. The chromatograms were performed with a reversed-phase C18 column with UV detector. The mobile phase consisted of acetonitrile, phosphate buffer (pH 3) and 1-octanesulfonic acid at a flow rate of 1 ml/min. Good linearity and recovery were achieved over the range of standard curves. The relative standard deviations of three quality controls for intra- and inter-day precision were less than 6.4%, and the relative errors of the intra- and inter-day accuracy were less than 7.0%. Tigecycline in Hank's buffer, PMNs and serum was stable under different test conditions. This new liquid chromatography assay is a simple, accurate and reproducible method for determining tigecycline in different matrix. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 8 条
[1]   Simple and reliable method of doxycycline determination in human plasma and biological tissues [J].
Axisa, B ;
Naylor, AR ;
Bell, PRF ;
Thompson, MM .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 744 (02) :359-365
[2]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF DOXYCYCLINE [J].
DELEENHEER, AP ;
NELIS, HJCF .
JOURNAL OF CHROMATOGRAPHY, 1977, 140 (03) :293-299
[3]   Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L-pneumophila pneumonia [J].
Edelstein, PH ;
Weiss, WJ ;
Edelstein, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :533-540
[4]   Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis [J].
Murphy, TM ;
Deitz, JM ;
Petersen, PJ ;
Mikels, SM ;
Weiss, WJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3022-3027
[5]   Activity of tigecycline (GAR-936), a novel glycylcycline, against enterococci in the mouse peritonitis model [J].
Nannini, EC ;
Pai, SR ;
Singh, KV ;
Murray, BE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :529-532
[6]   In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936) [J].
Petersen, PJ ;
Jacobus, NV ;
Weiss, WJ ;
Sum, PE ;
Testa, RT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :738-744
[7]   Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent [J].
Projan, SJ .
PHARMACOTHERAPY, 2000, 20 (09) :219S-223S
[8]   The glycylcyclines - A comparative review with the tetracyclines [J].
Zhanel, GG ;
Homenuik, K ;
Nichol, K ;
Noreddin, A ;
Vercaigne, L ;
Embil, J ;
Gin, A ;
Karlowsky, JA ;
Hoban, DJ .
DRUGS, 2004, 64 (01) :63-88